CLINICAL_TRIALS
trial_result
· 2021-06-28
Clinical Trial Update: Low-dose Intra-arterial Bevacizumab for Edema and Radiation Necrosis Therapeutic Intervention (LIBERTI) [Phase 2]
Summary
Phase 2 trial evaluating low-dose intra-arterial bevacizumab for radiation necrosis; the study has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Norton Healthcare | Conditions: Radiation Necrosis | Phase 2 | Status: COMPLETED | Results posted: 2021-06-28